The global empty capsule market is projected to be worth US$ 2,956.6 million in 2024. The sales of empty capsules are expected to expand at an 8% CAGR from 2024 to 2034, reaching US$ 6,378.6 million by 2034.
The rising frequency of chronic diseases and the spike in demand for dietary supplements are important factors compelling the empty capsule industry. Empty capsules are a quick and easy way to consume drugs. They are less prone to induce negative effects compared to other dose forms. These reasons are contributing to the increased demand for empty capsules.
Emerging Patterns in the Empty Capsule Sales
| Attributes | Details |
|---|---|
| Market Value for 2024 | US$ 2,956.6 million |
| Market Size for 2034 | US$ 6,378.6 million |
| Market CAGR from 2024 to 2034 | 8.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Consumer preferences for capsule dose forms are increasing due to convenience, ease of ingesting, and enhanced taste masking. Capsules are a convenient and edible alternative to standard dose forms such as tablets or powders. The gelatin or vegetarian shells used in empty capsules conceal the taste of substances, making them more appealing to customers.
Consumer preferences are shifting toward capsules as a preferred dose form in various businesses, escalating the sales of empty capsules. This trend emphasizes the value of empty capsules as a versatile and adaptable solution that meets changing consumer expectations for smooth and enjoyable healthcare experiences.
This section emphasizes providing an in-depth analysis of specific industrial regions. The analysis revolves around four crucial factors: gelatin-based capsules, type-B gelatin capsules, size "0" empty capsules, and oral administration alternatives.
With a predicted market share of 59.0% in 2024, the gelatin (hard) based capsules are projected to be the undeniable winner. This supremacy makes sense in light of the following:
| Leading Segment | Gelatin (Hard) Based Capsules |
|---|---|
| Segment Share | 59.0% |
With a 28.2% share predicted for 2024, the type-B gelatin segment is set to dominate the empty pill market. Several factors about the preference:
| Leading Segment | Type-B Gelatin |
|---|---|
| Segment Share | 28.2% |
With a predicted market share of 20.4% in 2024, the size "0" capsules are projected to be the undeniable winner. This supremacy makes sense in light of the following:
| Leading Segment | Size "0" Capsules |
|---|---|
| Segment Share | 20.4% |
With a 90.3% market share predicted for 2024, the oral administration segment is set to dominate the empty pill industry. Several factors about the preference:
| Leading Segment | Oral Administration |
|---|---|
| Segment Share | 90.3% |
Principal Consultant
This section explores markets in many key economies, including the United States, Canada, Japan, Germany, and Italy. It also examines the various factors influencing empty capsule demand, adoption, and sales in these nations. A detailed investigation shows North America offers significant growth opportunities due to its robust empty capsule manufacturers.
The United States empty pill market is anticipated to display a strong CAGR of 8.8% through 2034. This is explained by:
| Nation | United States |
|---|---|
| CAGR | 8.8% |
The empty pill market in Germany is expected to evolve at an 8.4% CAGR through 2034. This is outlined below:
| Nation | Germany |
|---|---|
| CAGR | 8.4% |
Japan empty capsule market is expected to develop at a robust CAGR of 7.8% through 2034 due to the increasing demand for nutraceuticals. This expansion is driven by:
| Country | Japan |
|---|---|
| CAGR | 7.8% |
The Canada empty pill market is expected to develop at a 6.2% CAGR through 2034. This expansion is sustained by:
| Nation | Canada |
|---|---|
| CAGR | 6.2% |
The Italy empty pill market is expected to expand at a low 3.2% CAGR through 2034. This is described as follows:
| Nation | Italy |
|---|---|
| CAGR | 3.2% |
In the competitive landscape of the empty capsule market, numerous important competitors have established themselves as significant contributors to the industry's growth and evolution. The empty capsule producers have shown dedication to innovation, dependability, and a wide range of competencies, altering market dynamics.
Empty capsule manufacturers such as ABC Capsules, Capsugel, and ACG Worldwide are at the forefront of innovation and have established themselves as dependable empty capsule suppliers. Prominent vendors such as Qualicaps and Suheung Co. Ltd. share their capabilities and demonstrate various offerings. CapsCanada Corporation, Shanxi Guangsheng Medicinal Capsule Co. Ltd., and Bright Pharma Caps Inc. are notable participants, each making a unique contribution to the empty pill market.
HealthCaps India Limited and Sunil Healthcare Limited enhance the competitive landscape by providing innovative solutions and insights. As these key competitors negotiate the shifting empty capsule demand, the path is set for ongoing advancements and competition, undoubtedly encouraging innovation and success in the sector.
Notable Innovations and Developments
| Company | Details |
|---|---|
| CapsCanada Corporation | CapsCanada Corporation received a substantial boost in November 2023 with a US$ 5 million investment from FedDev Ontario. This investment is likely to expand operations and fulfill increased demand for its made-in-Canada hard empty capsules. |
| Bright Pharma Caps Inc. | Bright Pharma Caps Inc. launched the world's first certified organic capsules, Bright-Poly, in August 2023. The capsules are manufactured of USDA-certified organic pullulan, which is NOP-approved and can be utilized in vegetarian, kosher, and halal products. |
| Vivion | Vivion, a leading ingredient solutions company, has introduced a new line of empty gelatin, HPMC, and pullulan capsules. |
| CapsCanada | CapsCanada, a Lyfe Group firm, announced in March 2021 the capsule manufacturing service for the new liquid-filled hard capsules. |
| Lonza Group Ltd. | Lonza Group Ltd. announced in October 2020 to invest US$ 93.0 million in its Capsules and Health Ingredients (CHI) Division, which allows the company to create 30 billion pills annually. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The demand for empty capsules to secure a valuation of US$ 2,956.6 million in 2024.
The sales of empty capsules are estimated to attain US$ 6,378.6 million by 2034.
Through 2034, the empty capsule industry is anticipated to expand at an 8.0% CAGR.
From 2019 to 2023, the sales of empty capsules recorded a 6.0% CAGR.
The gelatin-based capsules sector is set to achieve a share of 59.0%.
A 28.2% market share is expected for the type-B sector.
The size 0 capsules sector is set to achieve a share of 20.4%.
A 90.3% share is expected for the oral administration sector.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Product Type, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Product Type, 2024 to 2034
5.3.1. Gelatin Based Capsules
5.3.2. Vegetarian Based Capsules
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Raw Material
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Raw Material, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Raw Material, 2024 to 2034
6.3.1. Type-A
6.3.2. Type-B Gelatin
6.3.3. Fish Bone Gelatin
6.3.4. Hydroxy Propyl Methyl Cellulose (HPMC)
6.3.5. Starch Materials
6.3.6. Pullulan
6.4. Y-o-Y Growth Trend Analysis By Raw Material, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Raw Material, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Capsule Size
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Capsule Size, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Capsule Size, 2024 to 2034
7.3.1. Size "000"
7.3.2. Size "00"
7.3.3. Size "0"
7.3.4. Size "1"
7.3.5. Size "2"
7.3.6. Size "3"
7.3.7. Size "4"
7.3.8. Size "5"
7.4. Y-o-Y Growth Trend Analysis By Capsule Size, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Capsule Size, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Route of Administration, 2019 to 2023
8.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Route of Administration, 2024 to 2034
8.3.1. Oral Administration
8.3.2. Inhalation Administration
8.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2019 to 2023
8.5. Absolute $ Opportunity Analysis By Route of Administration, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By End User, 2019 to 2023
9.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By End User, 2024 to 2034
9.3.1. Pharmaceutical Companies
9.3.2. Cosmetic & Nutraceutical Companies
9.3.3. Clinical Research Organizations
9.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
9.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2019 to 2023
10.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2024 to 2034
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. South Asia and Pacific
10.3.6. East Asia
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. USA
11.2.1.2. Canada
11.2.2. By Product Type
11.2.3. By Raw Material
11.2.4. By Capsule Size
11.2.5. By Route of Administration
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Raw Material
11.3.4. By Capsule Size
11.3.5. By Route of Administration
11.3.6. By End User
11.4. Key Takeaways
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Product Type
12.2.3. By Raw Material
12.2.4. By Capsule Size
12.2.5. By Route of Administration
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Raw Material
12.3.4. By Capsule Size
12.3.5. By Route of Administration
12.3.6. By End User
12.4. Key Takeaways
13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. UK
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Product Type
13.2.3. By Raw Material
13.2.4. By Capsule Size
13.2.5. By Route of Administration
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Raw Material
13.3.4. By Capsule Size
13.3.5. By Route of Administration
13.3.6. By End User
13.4. Key Takeaways
14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. Poland
14.2.1.2. Russia
14.2.1.3. Czech Republic
14.2.1.4. Romania
14.2.1.5. Rest of Eastern Europe
14.2.2. By Product Type
14.2.3. By Raw Material
14.2.4. By Capsule Size
14.2.5. By Route of Administration
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Raw Material
14.3.4. By Capsule Size
14.3.5. By Route of Administration
14.3.6. By End User
14.4. Key Takeaways
15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Bangladesh
15.2.1.3. Australia
15.2.1.4. New Zealand
15.2.1.5. Rest of South Asia and Pacific
15.2.2. By Product Type
15.2.3. By Raw Material
15.2.4. By Capsule Size
15.2.5. By Route of Administration
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Raw Material
15.3.4. By Capsule Size
15.3.5. By Route of Administration
15.3.6. By End User
15.4. Key Takeaways
16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
16.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
16.2.1. By Country
16.2.1.1. China
16.2.1.2. Japan
16.2.1.3. South Korea
16.2.2. By Product Type
16.2.3. By Raw Material
16.2.4. By Capsule Size
16.2.5. By Route of Administration
16.2.6. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product Type
16.3.3. By Raw Material
16.3.4. By Capsule Size
16.3.5. By Route of Administration
16.3.6. By End User
16.4. Key Takeaways
17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
17.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023
17.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Israel
17.2.1.4. Rest of MEA
17.2.2. By Product Type
17.2.3. By Raw Material
17.2.4. By Capsule Size
17.2.5. By Route of Administration
17.2.6. By End User
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Product Type
17.3.3. By Raw Material
17.3.4. By Capsule Size
17.3.5. By Route of Administration
17.3.6. By End User
17.4. Key Takeaways
18. Key Countries Market Analysis
18.1. USA
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2023
18.1.2.1. By Product Type
18.1.2.2. By Raw Material
18.1.2.3. By Capsule Size
18.1.2.4. By Route of Administration
18.1.2.5. By End User
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2023
18.2.2.1. By Product Type
18.2.2.2. By Raw Material
18.2.2.3. By Capsule Size
18.2.2.4. By Route of Administration
18.2.2.5. By End User
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2023
18.3.2.1. By Product Type
18.3.2.2. By Raw Material
18.3.2.3. By Capsule Size
18.3.2.4. By Route of Administration
18.3.2.5. By End User
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2023
18.4.2.1. By Product Type
18.4.2.2. By Raw Material
18.4.2.3. By Capsule Size
18.4.2.4. By Route of Administration
18.4.2.5. By End User
18.5. Germany
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2023
18.5.2.1. By Product Type
18.5.2.2. By Raw Material
18.5.2.3. By Capsule Size
18.5.2.4. By Route of Administration
18.5.2.5. By End User
18.6. UK
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2023
18.6.2.1. By Product Type
18.6.2.2. By Raw Material
18.6.2.3. By Capsule Size
18.6.2.4. By Route of Administration
18.6.2.5. By End User
18.7. France
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2023
18.7.2.1. By Product Type
18.7.2.2. By Raw Material
18.7.2.3. By Capsule Size
18.7.2.4. By Route of Administration
18.7.2.5. By End User
18.8. Spain
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2023
18.8.2.1. By Product Type
18.8.2.2. By Raw Material
18.8.2.3. By Capsule Size
18.8.2.4. By Route of Administration
18.8.2.5. By End User
18.9. Italy
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2023
18.9.2.1. By Product Type
18.9.2.2. By Raw Material
18.9.2.3. By Capsule Size
18.9.2.4. By Route of Administration
18.9.2.5. By End User
18.10. Poland
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2023
18.10.2.1. By Product Type
18.10.2.2. By Raw Material
18.10.2.3. By Capsule Size
18.10.2.4. By Route of Administration
18.10.2.5. By End User
18.11. Russia
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2023
18.11.2.1. By Product Type
18.11.2.2. By Raw Material
18.11.2.3. By Capsule Size
18.11.2.4. By Route of Administration
18.11.2.5. By End User
18.12. Czech Republic
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2023
18.12.2.1. By Product Type
18.12.2.2. By Raw Material
18.12.2.3. By Capsule Size
18.12.2.4. By Route of Administration
18.12.2.5. By End User
18.13. Romania
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2023
18.13.2.1. By Product Type
18.13.2.2. By Raw Material
18.13.2.3. By Capsule Size
18.13.2.4. By Route of Administration
18.13.2.5. By End User
18.14. India
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2023
18.14.2.1. By Product Type
18.14.2.2. By Raw Material
18.14.2.3. By Capsule Size
18.14.2.4. By Route of Administration
18.14.2.5. By End User
18.15. Bangladesh
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2023
18.15.2.1. By Product Type
18.15.2.2. By Raw Material
18.15.2.3. By Capsule Size
18.15.2.4. By Route of Administration
18.15.2.5. By End User
18.16. Australia
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2023
18.16.2.1. By Product Type
18.16.2.2. By Raw Material
18.16.2.3. By Capsule Size
18.16.2.4. By Route of Administration
18.16.2.5. By End User
18.17. New Zealand
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2023
18.17.2.1. By Product Type
18.17.2.2. By Raw Material
18.17.2.3. By Capsule Size
18.17.2.4. By Route of Administration
18.17.2.5. By End User
18.18. China
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2023
18.18.2.1. By Product Type
18.18.2.2. By Raw Material
18.18.2.3. By Capsule Size
18.18.2.4. By Route of Administration
18.18.2.5. By End User
18.19. Japan
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2023
18.19.2.1. By Product Type
18.19.2.2. By Raw Material
18.19.2.3. By Capsule Size
18.19.2.4. By Route of Administration
18.19.2.5. By End User
18.20. South Korea
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2023
18.20.2.1. By Product Type
18.20.2.2. By Raw Material
18.20.2.3. By Capsule Size
18.20.2.4. By Route of Administration
18.20.2.5. By End User
18.21. GCC Countries
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2023
18.21.2.1. By Product Type
18.21.2.2. By Raw Material
18.21.2.3. By Capsule Size
18.21.2.4. By Route of Administration
18.21.2.5. By End User
18.22. South Africa
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2023
18.22.2.1. By Product Type
18.22.2.2. By Raw Material
18.22.2.3. By Capsule Size
18.22.2.4. By Route of Administration
18.22.2.5. By End User
18.23. Israel
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2023
18.23.2.1. By Product Type
18.23.2.2. By Raw Material
18.23.2.3. By Capsule Size
18.23.2.4. By Route of Administration
18.23.2.5. By End User
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Product Type
19.3.3. By Raw Material
19.3.4. By Capsule Size
19.3.5. By Route of Administration
19.3.6. By End User
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. ACG Worldwide
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.1.5.2. Product Strategy
20.1.1.5.3. Channel Strategy
20.1.2. Capsugel
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.2.5.2. Product Strategy
20.1.2.5.3. Channel Strategy
20.1.3. Qualicaps Inc.
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.3.5.2. Product Strategy
20.1.3.5.3. Channel Strategy
20.1.4. Bright Pharma Caps Inc.
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.4.5.2. Product Strategy
20.1.4.5.3. Channel Strategy
20.1.5. Medi-Caps Ltd.
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.5.5.2. Product Strategy
20.1.5.5.3. Channel Strategy
20.1.6. CapsCanada Corporation
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.6.5.2. Product Strategy
20.1.6.5.3. Channel Strategy
20.1.7. Roxlor LLC
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.7.5.2. Product Strategy
20.1.7.5.3. Channel Strategy
20.1.8. Snail Pharma Industry Co. Ltd.
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.8.5.2. Product Strategy
20.1.8.5.3. Channel Strategy
20.1.9. Suheung Co. Ltd.
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.9.5.2. Product Strategy
20.1.9.5.3. Channel Strategy
20.1.10. Sunil Healthcare Ltd
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
20.1.10.5.2. Product Strategy
20.1.10.5.3. Channel Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Empty Capsule Market
